We investigate how the confluence of technologies can lead to radical innovation, thus creating opportunities at the firm and industry levels. To do so, we conduct a detailed examination of the development of the transistor and of two nanobiotechnology drugs – Doxil® and Zevalin® – from an innovation management perspective. We argue that three innovation management strategies are central to the development of radical innovation from the confluence of technologies, namely: importing ideas from broad networks, creating environments which allow for deep collaboration, and technology-market matching.
This is the final author version (accepted manuscript copy following peer review).
Maine, E., Thomas, V., & Utterback, J. (2014). Radical innovation from the confluence of technologies: Innovation management strategies for the emerging nanobiotechnology industry. Journal Of Engineering & Technology Management, 321-25. doi:10.1016/j.jengtecman.2013.10.007http://www.sciencedirect.com/science/article/pii/S0923474813000775
Journal Of Engineering & Technology Management
Radical innovation from the confluence of technologies: Innovation management strategies for the emerging nanobiotechnology industry
Copyright is held by the author(s).
You are free to copy, distribute and transmit this work under the following conditions: You must give attribution to the work (but not in any way that suggests that the author endorses you or your use of the work); You may not use this work for commercial purposes.
Member of collection